Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
SOPH Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: June 22, 2026
Report Source: 2026 1st Quarter Report
SOPHiA GENETICS SA. Stock Analysis SOPH
United States Health Care Small Cap Report: SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. The company is headquartered in Rolle, Vaud and currently employs 415 full-time employees. The company went IPO on 2021-07-23. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The firm has offices in Switzerland, France, and the United States and operates worldwide.
Read More SOPHiA GENETICS SA (SOPH) Chart
Key Statistics of SOPHiA GENETICS SA (SOPH)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$5.29Volume
111.13KP/E Ratio (TTM)
-52 Week Range
Market Cap
361.93MAvg. Volume
195.95KDividend Yield
-Financial Metrics & Statements of SOPHiA GENETICS SA (SOPH)
FAQ's for SOPHiA GENETICS SA (SOPH)
- According to Musaffa’s Shariah screening methodology, SOPHiA GENETICS SA (SOPH) is currently classified as HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes SOPHiA GENETICS SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in SOPHiA GENETICS SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of SOPHiA GENETICS SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of SOPHiA GENETICS SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of SOPHiA GENETICS SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.